NIAB Hyderabad Vaccine Development SRF Vacancy


Advertisement No. 02/2022

Applications are invited from suitable candidate for filling up the following position at National Institute of Animal Biotechnology (NIAB), Hyderabad. One position of Senior Research Fellow against the SERB (DST) funded project entitled “Immunocharacterization of Lipopolysaccharide (LPS) from Leptospira: Towards development of LPS based vaccine”. 

PI: Dr. Syed M. Faisal, Scientist-E 

Fellowship amount: Rs.28000/-PM +30% HRA (if applicable) as per the DST guidelines. 

Eligibility: Post Graduate Degree in life sciences OR Graduate/Post Graduate degree in professional course having NET/GATE or selected through national level examination conducted by DBT/DST/MHRD/ICMR/IIT/IISC/IISSER. 

The candidate should have minimum two-year research experience preferably as JRF (Eligibility criteria as per DST OM No.SR/S9/Z-09/2012 dated 21.10.2014 and SR/S9/Z-08/2018 dated 30.01.2019). However, Non NET candidates can also apply who will be paid as per their eligibility. 

Experience: Candidate with experience in molecular biology and Immunological techniques and animal (mice, hamster) handling is desirable. Candidates having prior experience in working with Leptospira will be preferred. 

Age: 35 years (Relaxation is admissible in case of SC/ST/OBC candidates as per Government instructions) 

Interested candidates can send their biodata with documents in support of date of birth, educational qualifications, experience certificates etc. to Dr. Syed Mohd. Faisal, (Email ID: faisal@niab.org.in) on or before 15th January 2022 by 5 PM. Candidates meeting the essential and relevant criteria will be considered for an interview through video conferencing on 18th January 2022 from 10:00 AM onwards. Online Interview Link will be sent to the shortlisted candidates only. Walk-in Interview - 

More Info: www.niab.org.in/Notifications/Advt_2_2022/Notification_2_2022.pdf

Subscribe our Twitter Channel to get all updates: Join Now!

To Get All Updates from helpBIOTECH, Subscribe Now by Email

Post a Comment

0 Comments